- Home
- BBOT vs TRNS Comparison
BBOT vs TRNS Comparison
Compare BBOT & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBOT | TRNS |
|---|---|---|
| Founded | 2016 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 717.8M | 799.0M |
| IPO Year | 2024 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BBOT | TRNS |
|---|---|---|
| Price | $8.85 | $85.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $24.00 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 231.8K | 89.0K |
| Earning Date | 05-26-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.93 | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $331,877,000.00 |
| Revenue This Year | N/A | $21.75 |
| Revenue Next Year | N/A | $7.55 |
| P/E Ratio | ★ N/A | $610.57 |
| Revenue Growth | N/A | ★ 19.20 |
| 52 Week Low | $7.00 | $50.23 |
| 52 Week High | $14.87 | $100.00 |
Technical Indicators
Market Signals| Indicator | BBOT | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 40.47 |
| Support Level | $8.80 | $67.74 |
| Resistance Level | $9.53 | $85.20 |
| Average True Range (ATR) | 0.45 | 3.51 |
| MACD | -0.06 | -0.68 |
| Stochastic Oscillator | 29.92 | 19.55 |
Price Performance
Historical ComparisonAbout BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
About TRNS Transcat Inc.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.